Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses
Explore our Face Tonic, with Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7, for help with the appearance of fine lines and skin firmness
Zepbound (tirzepatide) posted even more impressive numbers: up to 22.5% weight loss at the highest dose over 72 weeks in the SURMOUNT-1 trial
As with any aesthetic treatment, informed decision-making starts with understanding what the therapy can and cannot do, what the experience involves, and why the quality of your provider matters
Protein helps determine whether your smaller meals support muscle, fullness, hair, energy, and recovery
Berberine, a key ingredient in many of the gummies reviewed here, should not be used during pregnancy or while nursing, as research indicates it may cause serious harm to infants, including potential brain damage